NCT00603447 Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00531284 Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00511238 Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00150462 Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies Status COMPLETED Phase PHASE1